BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 25692868)

  • 21. Prevalence of low bone mass in postmenopausal Kuwaiti women residents in the largest province of Kuwait.
    Al-Shoumer KA; Nair V
    Arch Osteoporos; 2012; 7():147-53. PubMed ID: 23225292
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term use of protease inhibitors is associated with bone mineral density loss.
    Kinai E; Nishijima T; Mizushima D; Watanabe K; Aoki T; Honda H; Yazaki H; Genka I; Tanuma J; Teruya K; Tsukada K; Gatanaga H; Kikuchi Y; Oka S
    AIDS Res Hum Retroviruses; 2014 Jun; 30(6):553-9. PubMed ID: 24494779
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of screening practices for low bone mass and prevalence of osteoporosis and fractures in people living with human immunodeficiency virus attending a sexual health clinic.
    Davidson N; Sowden D
    Intern Med J; 2019 Sep; 49(9):1119-1124. PubMed ID: 31081166
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adverse bone health and abnormal bone turnover among perinatally HIV-infected Asian adolescents with virological suppression.
    Sudjaritruk T; Bunupuradah T; Aurpibul L; Kosalaraksa P; Kurniati N; Prasitsuebsai W; Sophonphan J; Sohn AH; Ananworanich J; Puthanakit T;
    HIV Med; 2017 Apr; 18(4):235-244. PubMed ID: 27477214
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence and clinical determinants of low bone mineral density in anorexia nervosa.
    Hofman M; Landewé-Cleuren S; Wojciechowski F; Kruseman AN
    Eur J Intern Med; 2009 Jan; 20(1):80-4. PubMed ID: 19237098
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduced bone mineral density in human immunodeficiency virus-infected patients and its association with increased central adiposity and postload hyperglycemia.
    Brown TT; Ruppe MD; Kassner R; Kumar P; Kehoe T; Dobs AS; Timpone J
    J Clin Endocrinol Metab; 2004 Mar; 89(3):1200-6. PubMed ID: 15001610
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Controlled HIV viral replication, not liver disease severity associated with low bone mineral density in HIV/HCV co-infection.
    El-Maouche D; Mehta SH; Sutcliffe C; Higgins Y; Torbenson MS; Moore RD; Thomas DL; Sulkowski MS; Brown TT
    J Hepatol; 2011 Oct; 55(4):770-6. PubMed ID: 21338640
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of bone mineral density with dual x-ray absorptiometry for osteoporosis in children with bladder augmentation.
    Abeş M; Sarihan H; Madenci E
    J Pediatr Surg; 2003 Feb; 38(2):230-2. PubMed ID: 12596110
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bone mineral density correlation with fractures in nonambulatory pediatric patients.
    Khoury DJ; Szalay EA
    J Pediatr Orthop; 2007; 27(5):562-6. PubMed ID: 17585268
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low bone mineral density and risk of incident fracture in HIV-infected adults.
    Battalora L; Buchacz K; Armon C; Overton ET; Hammer J; Patel P; Chmiel JS; Wood K; Bush TJ; Spear JR; Brooks JT; Young B;
    Antivir Ther; 2016; 21(1):45-54. PubMed ID: 26194468
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low bone mass in human immunodeficiency virus-infected climacteric women receiving antiretroviral therapy: prevalence and associated factors.
    Gomes DC; Valadares AL; de Moraes MJ; Lagrutta BB; Pinto-Neto AM; Costa-Paiva L
    Menopause; 2015 Feb; 22(2):224-30. PubMed ID: 25003619
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Bone mineral density in postmenopausal women with proximal femoral fractures--comparative study between quantitative ultrasonometry and gold standard DXA].
    Schnabel M; Eser G; Ziller V; Mann D; Mann E; Hadji P
    Zentralbl Chir; 2005 Oct; 130(5):469-75. PubMed ID: 16220445
    [TBL] [Abstract][Full Text] [Related]  

  • 33. BMD is reduced in HIV-infected men irrespective of treatment.
    Amiel C; Ostertag A; Slama L; Baudoin C; N'Guyen T; Lajeunie E; Neit-Ngeilh L; Rozenbaum W; De Vernejoul MC
    J Bone Miner Res; 2004 Mar; 19(3):402-9. PubMed ID: 15040828
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased risk factors associated with lower BMD in antiretroviral-therapy-naïve HIV-infected adult male.
    Atencio P; Cabello A; Conesa-Buendía FM; Pérez-Tanoira R; Prieto-Pérez L; Carrillo I; Álvarez B; Arboiro-Pinel R; Díaz-Curiel M; Herrero-Beaumont G; Mediero A; Górgolas M
    BMC Infect Dis; 2021 Jun; 21(1):542. PubMed ID: 34107907
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bone mineral density among children living with HIV failing first-line anti-retroviral therapy in Uganda: A sub-study of the CHAPAS-4 trial.
    Natukunda E; Szubert A; Otike C; Namyalo I; Nambi E; Bamford A; Doerholt K; Gibb DM; Musiime V; Musoke P
    PLoS One; 2023; 18(7):e0288877. PubMed ID: 37471330
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immediate Initiation of Antiretroviral Therapy for HIV Infection Accelerates Bone Loss Relative to Deferring Therapy: Findings from the START Bone Mineral Density Substudy, a Randomized Trial.
    Hoy JF; Grund B; Roediger M; Schwartz AV; Shepherd J; Avihingsanon A; Badal-Faesen S; de Wit S; Jacoby S; La Rosa A; Pujari S; Schechter M; White D; Engen NW; Ensrud K; Aagaard PD; Carr A;
    J Bone Miner Res; 2017 Sep; 32(9):1945-1955. PubMed ID: 28650589
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reduced bone mineral density in HIV-infected patients: prevalence and associated factors.
    Cazanave C; Dupon M; Lavignolle-Aurillac V; Barthe N; Lawson-Ayayi S; Mehsen N; Mercié P; Morlat P; Thiébaut R; Dabis F;
    AIDS; 2008 Jan; 22(3):395-402. PubMed ID: 18195566
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of growth hormone treatment on bone mineral density in prepubertal girls with Turner syndrome: a multicentre prospective clinical trial.
    Aycan Z; Cetinkaya E; Darendeliler F; Vidinlisan S; Bas F; Bideci A; Demirel F; Darcan S; Buyukgebiz A; Yildiz M; Berberoglu M; Bundak R
    Clin Endocrinol (Oxf); 2008 May; 68(5):769-72. PubMed ID: 17980015
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence and risk factors of osteopenia/osteoporosis in Turkish HIV/AIDS patients.
    Aydın OA; Karaosmanoglu HK; Karahasanoglu R; Tahmaz M; Nazlıcan O
    Braz J Infect Dis; 2013; 17(6):707-11. PubMed ID: 24076108
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dairy calcium intake and lifestyle risk factors for bone loss in hiv-infected and uninfected Mediterranean subjects.
    Li Vecchi V; Soresi M; Giannitrapani L; Mazzola G; La Sala S; Tramuto F; Caruso G; Colomba C; Mansueto P; Madonia S; Montalto G; Di Carlo P
    BMC Infect Dis; 2012 Aug; 12():192. PubMed ID: 22894751
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.